Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy
β Scribed by Mary V. Relling; Raymond K. Mulhern; Diane Fairclough; Donald Baker; Ching-Hon Pul
- Book ID
- 117162540
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 530 KB
- Volume
- 123
- Category
- Article
- ISSN
- 1097-6833
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The safety and efficacy of the new 5HTβ3 antagonist granisetron as an antiemetic in children with cancer was evaluated in 40 children at a single dose of 40 ΞΌg/kg. No adverse affects attributable to the granisetron were noted. The overall major and complete response rate was 82.5% and t
Thirty-seven patients with advanced incurable malignancies who were receiving their first course of cisplatin (2 90 mg/mz bolus), alone or in combination with other antineoplastic agents, were entered in this randomized, double-blind study to determine the antiemetic efficacy of the addition of high
## Abstract Selective 5βHT~3~ receptor antagonists such as ondansetron are potent antiemetics for chemotherapyβinduced emesis. Ondansetron has been shown to be highly effective in preventing nausea and vomiting in children treated with chemotherapy and/or radiotherapy. However, its high cost may li